Evaluation of the nutritional and inflammatory status in cancer patients for the risk assessment of severe haematological toxicity following chemotherapy
J. Alexandre(Groupe Hospitalier Cochin - Port-Royal, Hôtel-Dieu, Broca - La Collégiale), François Goldwasser(Hôpital Cochin), Bruno Falissard(Inserm), M. Gross-Goupil(Bordeaux Population Health), J.M. Gornet(Université Paris Cité), J.L. Misset(Hôpital Saint-Louis), M.-L. Nguyen(Groupe Hospitalier Cochin - Port-Royal, Hôtel-Dieu, Broca - La Collégiale)
Cited by 133
Related Papers
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
|Science|2017|5.4k
Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma
|Journal of Clinical Oncology|2011|1.3k
Amoxicillin plus clavulanic acid versus appendicectomy for treatment of acute uncomplicated appendicitis: an open-label, non-inferiority, randomised controlled trial
|The Lancet|2011|674
Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer
|Nature Medicine|2022|637
Complicated grief after death of a relative in the intensive care unit
|European Respiratory Journal|2015|359